A.R.C. Laser founded
A.R.C. Laser GmbH established in Nürnberg, Germany.
For almost a decade, TruBlue has set the standard for precision laser surgery in ENT — the deepest clinical evidence base and the most complete product portfolio in the category.
When A.R.C. introduced TruBlue, it established an entirely new approach to laser surgery in ENT — for the first time, surgeons could harness the unique tissue interaction of blue laser energy on the most delicate structures of the voice, ear, and airway. Since then, blue laser has become an essential tool in modern ENT, and TruBlue remains the platform that defined the field — continuing to evolve with capabilities no other blue laser system can match, backed by decades of A.R.C. laser engineering.
TruBlue is part of a comprehensive surgical laser portfolio designed to support ENT surgeons across multiple applications — integrating wavelengths, fibers, accessories, and compatible technologies that enable surgeons to treat a variety of conditions with a single, proven system.
The platform that introduced blue laser surgery to ENT. 445 nm precision cutting with simultaneous photothermal coagulation — no other single wavelength delivers both.
Next generation. Adds PentaPulse (five emission modes including PeakPulse + PowerPulse) and FlowControl (CO₂ cooling + integrated smoke evacuation) — expanding what 445 nm can do.
A complete surgical ecosystem built around the TruBlue platform. HiFLEX fibers carry 445 nm through rigid and flexible endoscopes — moving between the OR and the office, replacing multiple laser platforms with one proven system.
Before TruBlue, ENT laser surgery had an unsolved problem: no single wavelength could cut precisely and coagulate effectively.
CO₂ excels at cutting but offers poor hemostasis. KTP achieves photoangiolysis, but cutting is limited — and the platform is no longer in production. The 445 nm wavelength proved both capabilities can coexist in a portable, fiber-delivered system.
The 445 nm wavelength sits at a peak of oxyhemoglobin absorption that exceeds both KTP (532 nm) and argon (514 nm), while remaining largely transparent to water. This photoangiolytic effect enables selective targeting of subepithelial vasculature while protecting the overlying epithelium.
High hemoglobin absorption with minimal thermal spread — reduces scarring risk and preserves the vibratory layer.
Significant fibrosis observed in vocal folds after KTP treatment; no such evidence in Wolf TruBlue cases.
The 445 nm absorption profile lets surgeons maintain visibility while controlling bleeding.
Touch or near-touch technique for vascular lesions: effective coagulation with virtually no thermal effect on adjacent epithelium.
Vaporization of Tis, T1, and T2 glottic cancer tumors with close margins while preserving oncologic outcomes.
Early laryngeal validation: 445 nm produces CO₂-like non-contact cutting with simultaneous photoangiolytic coagulation.
TruBlue's unique tissue interaction properties make it a versatile tool across ENT subspecialties. Select an application to explore the clinical context, featured procedures, and supporting literature.
Peer-reviewed publications — spanning laryngology, otology, rhinology, phonosurgery, and general otorhinolaryngology. Filter by specialty, open a card to read the full abstract with DOI.
Download the complete PDF brochure with all 34 abstracts, DOI links, and citation metadata. 7 years of 445 nm blue laser clinical experience in a single document.
Since 1996, A.R.C. has developed precision tools for surgeons who operate in the most delicate anatomical environments — consistently partnering with clinicians to push what laser surgery can achieve.
TruBlue is used by laryngologists across three regions — clinical collaborators and reference users who have shaped how blue laser surgery is practiced. Every entry below is a practicing physician, not a distributor.
A.R.C. works closely with physicians and academic institutions to support education and training in laser-based ENT surgery — workshops, clinical collaborations, and programs that help surgeons use TruBlue effectively and safely.
Clinical webinars, scientific topics, and research resources — free for registered HCPs.
Live streaming of surgical procedures with moderated Q&A from operating surgeons.
On-site demonstration with an A.R.C. clinical specialist. Evaluate TruBlue against your current platform.
Connect with your local representative to discuss procedure fit, pricing, and regional availability.
PDF library of peer-reviewed publications with DOI links — read before you commit.